| Name | 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine |
|---|---|
| Synonyms |
1-METHYL-7-AZAINDOLE-5-BORONIC ACID PINACOL ESTER
(S)-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine 1-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-PYRROLO[2,3-B]PYRIDINE 1-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLO[2,3-B]PYRIDINE |
| Molecular Formula | C14H19BN2O2 |
|---|---|
| Molecular Weight | 258.12400 |
| Exact Mass | 258.15400 |
| PSA | 36.28000 |
| LogP | 1.87250 |
|
~%
1220696-34-3 |
| Literature: NOVARTIS AG; FURET, Pascal; IMBACH, Patricia; MAH, Robert; STAUFFER, Frederic Patent: WO2010/139747 A1, 2010 ; Location in patent: Page/Page column 106 ; WO 2010/139747 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |